PACT Pharma

PACT Pharma Overview

Founded 2016
Founded
Status Private
Employees 95
Employees
Latest Deal Type Series C
Latest Deal Amount $75M
Latest Deal Amount
Investors 12

PACT Pharma General Information

Description

Developer of personalized adoptive T cell therapies designed for the eradication of solid tumors. The company's therapies help in the identification of neo-epitopes that serve as private mutations for each patient's cancer as well as creates an opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 2 Corporate Drive
  • San Francisco, CA 94080
  • United States

PACT Pharma Timeline

2017201820192020
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PACT Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 10-Jan-2020 $75M 00000 00000 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series B) 25-May-2018 0000 00000 00000 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 20-Dec-2016 $32.8M $32.8M 000.00 Completed Clinical Trials - Phase 1

PACT Pharma Cap Table

To view PACT Pharma‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 29,999,999 $0.000100 $0.08 $1 $1 1x $1 20.47%

PACT Pharma Executive Team (10)

Name Title Board Seat Contact Info
Alex Franzusoff Ph.D Chief Executive Officer
Timothy Moore Chief Technology Officer, Chief Technical Officer & President
Atulya Agarwal JD Chief Legal and Compliance Officer & Corporate Secretary
David Baltimore Ph.D Scientific Co-Founder & Chairman of Scientific Advisory Board
Juan Jaen Ph.D Co-Founder & Board Member

PACT Pharma Board Members (9)

To view PACT Pharma‘s full board member team, request access »
Name Representing Role Since
Antoni Ribas Ph.D PACT Pharma Member of Scientific Advisory Board, Scientific Co-Founder and Board Member 000 0000
Blake Byers Ph.D Self Chairman 000 0000
David Baltimore Ph.D PACT Pharma Scientific Co-Founder & Chairman of Scientific Advisory Board 000 0000
Helen Kim Vida Ventures (Boston) Board Member 000 0000
James Heath Ph.D PACT Pharma Scientific Co-Founder & Board Member 000 0000

PACT Pharma Investors (12)

To view PACT Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vida Ventures (Boston) Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial